Moreover, hyperinsulinemia may also promote breast cancer by increasing circulating estrogen levels, a factor that has been associated with breast cancer risk in postmenopausal women [39] and is also associated with the activation of insulin/IGF signaling, and dyslipidemia, which are commonly considered mechanisms involved in breast cancer. The gene discussed is INS; the disease is Hyperinsulinemia.